The company said it will stop the Phase III trial of ExPEC after interim results found it failed to demonstrate efficacy over placebo.
A series of reports released today by the European Centre for Disease Prevention and Control (ECDC) show sexually transmitted ...
The rate of antiviral prescriptions was 67% lower in pregnant than in nonpregnant women, including those with 1 or more ...